The Bharat Biotech company is working hard to find a drug that will help in the fight against the Covid-19 pandemic.
Regeneration, June 30, 2020. India authorized pharmaceutical company Bharat Biotech to start testing of a human Covid-19 vaccine.
In this way the company will be able to start a Phase I and II clinical trial of Covaxin, which it develops together with the National Institute of Virology, of the Indian Council of Medical Research.
According to the . news agency, this is the first company to be licensed by the local regulator for a drug against the SARS-COV-2 virus.
Likewise, the company announced that the trials in people will begin in July. The vaccine was developed and produced at the Bharat Biotech facility in the Genome Valley in Hyderabad, India.
In addition to Covaxin, Bharat Biotech also develops a nasal vaccine called CoroFlu, a treatment against Covid-19.
CoroFlu was performed in collaboration with virologists from the University of Wisconsin-Madison and the vaccine company FluGen.
CoroFlu is expected to start human testing in the fall of this year.